Capstone Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,400
Closed -$835K 1714
2022
Q3
$835K Buy
3,400
+1,500
+79% +$405K 0.01% 1102
2022
Q2
$470K Sell
1,900
-7,400
-80% -$2M ﹤0.01% 1266
2022
Q1
$3.08M Sell
9,300
-2,600
-22% -$800K 0.01% 880
2021
Q4
$4.27M Sell
11,900
-3,700
-24% -$1.25M 0.01% 870
2021
Q3
$5.08M Buy
15,600
+1,600
+11% +$542K 0.01% 852
2021
Q2
$4.37M Sell
14,000
-3,800
-21% -$1.17M 0.01% 759
2021
Q1
$5.67M Buy
17,800
+4,800
+37% +$1.54M 0.02% 614
2020
Q4
$4.21M Buy
13,000
+2,400
+23% +$664K 0.01% 650
2020
Q3
$2.94M Buy
10,600
+1,200
+13% +$346K 0.02% 679
2020
Q2
$2.27M Buy
9,400
+2,400
+34% +$482K 0.02% 675
2020
Q1
$1.02M Sell
7,000
-2,500
-26% -$415K 0.02% 708
2019
Q4
$1.62M Sell
9,500
-5,700
-38% -$1.06M 0.01% 900
2019
Q3
$2.7M Buy
15,200
+3,600
+31% +$778K 0.02% 636
2019
Q2
$3.02M Buy
11,600
+2,700
+30% +$716K 0.02% 620
2019
Q1
$2.54M Buy
8,900
+2,500
+39% +$831K 0.02% 522
2018
Q4
$2.08M Buy
6,400
+4,600
+256% +$1.6M 0.03% 433
2018
Q3
$810K Buy
+1,800
New +$710K 0.01% 663

Other funds holding ABMD

Capstone Investment Advisors's ABMD Position: Q4 2022 in Review

Capstone Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 667 shares — an estimated $164K sold.

Capstone Investment Advisors first reported a position in ABMD in Q2 2017 and held it in 9 quarters. The position peaked at $4.57M in Q2 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Capstone Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 667 Abiomed Inc shares in Q4 2022, an estimated $164K.
  • Capstone Investment Advisors first reported a position in Abiomed Inc in Q2 2017 and held it in 9 quarters.
  • Capstone Investment Advisors's Abiomed Inc position peaked at $4.57M in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capstone Investment Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.